Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from NFL Biosciences SA ( (FR:ALNFL) ) is now available.
NFL Biosciences has announced its financial agenda for 2025, detailing key dates for the release of its annual and semi-annual results, as well as its General Assembly. This announcement provides stakeholders with a timeline of important financial disclosures, potentially impacting investor relations and market perceptions.
More about NFL Biosciences SA
NFL Biosciences is a biopharmaceutical company located in Montpellier, France, focusing on developing plant-based drug candidates for treating addictions. The company aims to provide natural, safer, and effective therapeutic solutions globally, including in low and middle-income countries. Its leading product, NFL-101, is a tobacco leaf extract designed to help smokers quit, and it is also working on NFL-301 for reducing alcohol consumption and a treatment for cannabis use disorders.
YTD Price Performance: -5.80%
Technical Sentiment Consensus Rating: Buy
See more data about ALNFL stock on TipRanks’ Stock Analysis page.